Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pharmacy-Based PrEP could transform HIV prevention for young women in tanzania

NCT ID NCT07687888

Not yet recruiting Prevention Sponsor: Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study explores whether offering HIV prevention medication (PrEP) through pharmacies can help more young women aged 18-24 in Tanzania access and consistently use it. Researchers compare four different pharmacy-based service models to standard care, and later test cost-sharing approaches to improve long-term sustainability. The goal is to find practical ways to reach young women who may not otherwise get PrEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PrEP (pre-exposure prophylaxis) and HIV self-test kits
What this could lead to
If successful, this could make HIV prevention more accessible and sustainable for young women in Tanzania through pharmacy-based services.
What could go wrong
This is an implementation study, not a test of PrEP's effectiveness. Results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

posterior leukoencephalopathy syndrome HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREP

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Health for a Prosperous Nation

    Dar es Salaam, Tanzania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.